American Association for Cancer Research
Vaccine against HER2-positive breast cancer offers complete protection in lab
Published in Cancer Weekly, September 30th, 2008
The study, reported in the September 15 issue of Cancer Research, a journal of the American Association for Cancer Research, suggests the vaccine could treat women with HER2-positive, treatment-resistant cancer or help prevent cancer recurrence. The researchers also say it might potentially be used in cancer-free women to prevent initial development of these tumors.
HER2 receptors promote normal cell growth, and are found in low amounts on...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-09-30)
More Articles from Cancer Weekly
- World Journal of Gastroenterology
Gastric cancer with 3 pathological features - BioSante Pharmaceuticals, Inc.
Let's Get It On - Cancer Gene Therapy
Epeius Biotechnologies' Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal - Cancer Gene Therapy
Research from Kitasato University, Medical Department has provided new information about cancer gene therapy - Cancer Gene Therapy
Research on cancer gene therapy detailed by scientists at Mayo Clinic - Cancer Vaccines
DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
